NYSE:ALBChemicals
Is Albemarle’s (ALB) Lithium Cash Flow Ambition Altering The Investment Case For Albemarle (ALB)?
In recent days, Albemarle has drawn renewed attention as analysts highlighted the company’s stronger balance sheet, cost controls, and preparations for a recovery in lithium carbonate equivalent prices, alongside upbeat expectations ahead of its early May 2026 earnings release and an expanded cash tender offer of up to US$650 million for outstanding notes.
A key takeaway from this past commentary is that Albemarle now expects EBITDA margins above 50% and annual free cash flow above...